Industry News
Biotechnology Industry News

Transatlantic VC veterans tap Novo Holdings to raise $124M rare disease fund
Transatlantic VC veterans tap Novo Holdings to raise $124M rare disease fund ntaylor Tue, 01/04/2022 - 05:41
With $415M on the line, Genmab taps Synaffix for antibody-drug conjugate technologies
With $415M on the line, Genmab taps Synaffix for antibody-drug conjugate technologies ntaylor Mon, 01/03/2022 - 10:01
AstraZeneca taps Ionis to join crowd of companies gunning for rare heart disease in deal worth billions in biobucks
AstraZeneca taps Ionis to join crowd of companies gunning for rare heart disease in deal worth billions in biobucks aarmstrong Wed, 12/29/2021 - 10:08
Biogen-Eisai’s potential Aduhelm sequel drug granted speedy review by FDA
Biogen-Eisai's potential Aduhelm sequel drug granted speedy review by FDA aarmstrong Mon, 12/27/2021 - 10:56
Editor’s Corner: Fierce Biotech’s top 10 most read stories in 2021
Editor's Corner: Fierce Biotech's top 10 most read stories in 2021 aarmstrong Wed, 12/22/2021 - 09:04
Novartis inks $800M upfront buyout of Gyroscope to continue eye disease gene therapy M&A spree
Novartis inks $800M upfront buyout of Gyroscope to continue eye disease gene therapy M&A spree ntaylor Wed, 12/22/2021 - 03:29
Aiming to make 70 the new 50, Korify rolls out $100M longevity and mental health venture fund
Aiming to make 70 the new 50, Korify rolls out $100M longevity and mental health venture fund ntaylor Wed, 12/22/2021 - 01:50
PhaseBio blames COVID-19 disruption as cardiovascular study axed
PhaseBio blames COVID-19 disruption as cardiovascular study axed aarmstrong Tue, 12/21/2021 - 09:20
Pfizer reports patient death in early-stage Duchenne gene therapy trial, halts enrollment
Pfizer reports patient death in early-stage Duchenne gene therapy trial, halts enrollment aarmstrong Tue, 12/21/2021 - 08:39
Abandoned by Amgen, Cytokinetics lands deal for Chinese rights to heart failure prospect
Abandoned by Amgen, Cytokinetics lands deal for Chinese rights to heart failure prospect ntaylor Tue, 12/21/2021 - 07:51
Abandoned by Amgen, Cytokinetics lands $50M upfront deal for Chinese rights to heart failure prospect
Abandoned by Amgen, Cytokinetics lands $50M upfront deal for Chinese rights to heart failure prospect ntaylor Tue, 12/21/2021 - 07:51
Sanofi gambles $1B upfront on preclinical oncology biotech, bagging Amunix for its pipeline of T-cell engagers
Sanofi gambles $1B upfront on preclinical oncology biotech, bagging Amunix for its pipeline of T-cell engagers ntaylor Tue, 12/21/2021 - 07:17
Chutes & Ladders—CRISPR Therapeutics bids adieu to R&D head in securities filing
Chutes & Ladders—CRISPR Therapeutics bids adieu to R&D head in securities filing fkansteiner Tue, 12/21/2021 - 07:03
The Alzheimer’s debate may not seem positive, but AC Immune’s CEO promises it’s been a breakthrough year
The Alzheimer's debate may not seem positive, but AC Immune's CEO promises it's been a breakthrough year aarmstrong Mon, 12/20/2021 - 19:53
2022 forecast: We wish we had better news for biotech dealmaking, but omicron is coming anyway
2022 forecast: We wish we had better news for biotech dealmaking, but omicron is coming anyway aarmstrong Mon, 12/20/2021 - 15:15
No data, no problem. Senti will go public in $296M SPAC deal before hitting the clinic
No data, no problem. Senti will go public in $296M SPAC deal before hitting the clinic aarmstrong Mon, 12/20/2021 - 13:06
Aptose finally ditches APTO-253 after 3-year clinical hold, phase 1 dud
Aptose finally ditches APTO-253 after 3-year clinical hold, phase 1 dud aarmstrong Mon, 12/20/2021 - 11:59
This is just the Spark: Roche’s new gene therapy manufacturing center leaves space for growth
This is just the Spark: Roche's new gene therapy manufacturing center leaves space for growth aarmstrong Mon, 12/20/2021 - 10:50
Roche adds to Genentech’s ophthalmology program with $670M in biobucks for Lineage Cell Therapeutics’ asset
Roche adds to Genentech's ophthalmology program with $670M in biobucks for Lineage Cell Therapeutics' asset aarmstrong Mon, 12/20/2021 - 10:12
Novartis brings on first TIGIT drug in massive billion-dollar biobucks deal with BeiGene
Novartis brings on first TIGIT drug in massive billion-dollar biobucks deal with BeiGene aarmstrong Mon, 12/20/2021 - 09:37

